Illumina (MIL:1ILMN) Operating Margin %: 19.16% (As of Mar. 2026) — Near Median


MIL:1ILMN Illumina Inc MIL:1ILMN
49 GF Score
Price €143.82
GF Value €104.58
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Illumina Operating Margin %?

Illumina MIL:1ILMN 49 Operating Margin % is 19.16% as of Mar. 2026, which is 4% above its 10-year median of 18.36. GuruFocus rates MIL:1ILMN with a GF Score™ of 49/100 and a GF Value™ of €104.58 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Illumina ranks better than 87.25% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. Illumina's Operating Income for the three months ended in Mar. 2026 was €181 Mil. Illumina's Revenue for the three months ended in Mar. 2026 was €944 Mil. Therefore, Illumina's Operating Margin % for the quarter that ended in Mar. 2026 was 19.16%.

The historical rank and industry rank for Illumina's Operating Margin % or its related term are showing as below:

MIL:1ILMN' s Operating Margin % Range Over the Past 10 Years
Min: -4.93   Med: 18.36   Max: 27.8
Current: 19.6


MIL:1ILMN's Operating Margin % is ranked better than
87.25% of 204 companies
in the Medical Diagnostics & Research industry
Industry Median: -3.195 vs MIL:1ILMN: 19.60

Illumina's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Illumina's Operating Income for the three months ended in Mar. 2026 was €181 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was €740 Mil.


Illumina  (MIL:1ILMN) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Illumina Operating Margin % Related Terms


Illumina Operating Margin % Historical Data

* Premium members only.

The historical data trend for Illumina's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Illumina Operating Margin % Chart

Illumina Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.72 7.72 -4.93 13.72 18.81

Illumina Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.75 20.21 20.94 18.21 19.16

MIL:1ILMN vs MTD, DGX, LH: Operating Margin % Comparison

For the Diagnostics & Research subindustry, Illumina's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Illumina Operating Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Illumina's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Illumina's Operating Margin % falls into.


MIL:1ILMN
49GF Score
Illumina Inc MIL:1ILMN
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Illumina Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Illumina's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=697.718 / 3708.922
=18.81 %

Illumina's Operating Margin % for the quarter that ended in Mar. 2026 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=180.785 / 943.715
=19.16 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of 19.16% mean?
Illumina (MIL:1ILMN) has a Operating Margin % of 19.16% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Illumina and its competitors. This is near median its historical median of 18.36. According to the industry distribution chart, Illumina ranks #26 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 12.7%.
Is Illumina's Operating Margin % too high?
Illumina's current Operating Margin % of 19.16% is near median its 10-year median of 18.36. Based on the distribution chart, Illumina ranks #26 out of 204 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Illumina has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Illumina's Operating Margin % compare to MTD and DGX?
According to the Medical Diagnostics & Research industry distribution chart, Illumina ranks #26 out of 204 companies for Operating Margin %. This places Illumina in the top 13% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Diagnostics & Research company?
A good Operating Margin % depends on the Medical Diagnostics & Research industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Illumina and its competitors. Illumina's current Operating Margin % is 19.16%, which is near median its own 10-year median of 18.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Illumina stock overvalued right now?
Based on GuruFocus' analysis, Illumina (MIL:1ILMN) is currently considered Significantly Overvalued. The stock's GF Value™ is €104.58, compared to a current price of €143.82 — trading 37.5% above its estimated fair value. The current Operating Margin % is 19.16%, which is near median its 10-year median of 18.36. Illumina's overall GF Score™ is 49/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Illumina (MIL:1ILMN), the current Operating Margin % is 19.16% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Illumina (MIL:1ILMN) Overvalued in 2026?

Based on GuruFocus' analysis, Illumina stock appears to be overvalued. The current stock price of €143.82 is trading 37.5% above its estimated GF Value™ of €104.58. GuruFocus considers Illumina to be Significantly Overvalued.

Key valuation signals for MIL:1ILMN:

  • Operating Margin %: 19.16% (near median its 10-year median of 18.36)
  • GF Value™: €104.58 vs. price of €143.82 (37.5% above fair value)
  • GF Score™: 49/100 with 7 warning signs

No single metric tells the full story. See the MIL:1ILMN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Illumina Business Description

Address 5200 Illumina Way, San Diego, CA, USA, 92122
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
49GF Score

Get the complete analysis for MIL:1ILMN

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€143.82
Price
€104.58
GF Value